Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,598 results that match your search.22,598 results
  • SIPO published an amendment proposal on the Patent Examination Guidelines 2010 on February 4 2013, and invites comments from the public by March 18 2013.
  • A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam – who received the world’s first recorded patent in 1449 diary@managingip.com
  • The rash of mergers between Australian and international firms has led to many IP owners shifting work to smaller IP firms. Faye McCarthy explains
  • Article 84 of the European Patent Convention (EPC) governs the clarity and conciseness of the claims in a European patent. It is well known that objections to the clarity of a claim cannot constitute a ground of opposition under article 100. However, clarity issues can be taken up in opposition proceedings by means of article 103.
  • Article 10.1.8 of the PRC Trademark Law provides that where a trade mark is detrimental to socialist morals or customs, or has other adverse effects, it shall not be approved for trade mark registration. The PRC Supreme Court's No 12 Opinion (2010) further clarifies that the "other adverse effects" refer to when the mark or its elements would likely raise negative and unhealthy influences on China's political, economic, cultural, religious and ethnic public interests and public order. However, Chinese laws do not provide specific criteria for deciding these adverse effects.
  • The Committee on Price Negotiation of Patented Drugs released a draft proposal recently. In it, the Committee has very clearly noted the difficulty it faces. On the one hand, the prices of patented drugs in India are high compared to other countries, when normalised based on gross national income with purchasing power parity. On the other hand, unilateral fixing of prices by the Government may stop the patented drug being available.
  • Emre Kerim Yardimci of Deris Patents and Trademarks Agency explains the proposed amendments to patent legislation in Turkey, where investment and filings are increasing year on year
  • The world's leading copyright firms, ranked across 21 jurisdictions
  • Ugur Aktekin, Özge Atilgan Karakulak and Hande Hançer of Mehmet Gün & Partners counter the perception that Turkey’s enforcement tools are inefficient, and detail the best ways to tackle infringement
  • Apioneer batch of 20 people comprising IP professionals, bankers, accountants and venture capitalists commenced training on IP valuation in March this year. The training is being jointly organised by the Malaysian IP Office (MyIPO) and the government agency responsible for driving the ICT industry in Malaysia, Multimedia Development Corporation (MDeC). The intensive training modules were formulated in collaboration with local IP professionals and IP valuation experts and trainers from Switzerland, the UK and the United States.